IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
The myeloperoxidase-463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls
Chang, Cuixian1; Gao, Baorong2; Liu, Zheng1; Mao, Jianbin1; Jiang, Guoqiang1
关键词Myeloperoxidase Polymorphism Coronary artery disease Atherosclerosis Meta-analysis
刊名CLINICAL BIOCHEMISTRY
2013-11-01
DOI10.1016/j.clinbiochem.2013.09.002
46期:16-17页:1644-1648
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medical Laboratory Technology
研究领域[WOS]Medical Laboratory Technology
关键词[WOS]MYOCARDIAL-INFARCTION ; HEALTHY-INDIVIDUALS ; LUNG-CANCER ; POPULATION ; ATHEROSCLEROSIS ; ASSOCIATION ; GENE
英文摘要

Objectives: Genetic polymorphism of human myeloperoxidase (MPO) -463G/A has been implicated to alter the risk of coronary artery disease (CAD), but the results are controversial. To improve the reliability of the conflicting results, we conducted a meta-analysis of studies relating the MPO -463G/A polymorphism with the risk of CAD.

Design and methods: Two investigators independently searched the MEDLINE, EMBASE and Cochrane Library up to June, 2012. Summary odds ratios (OR) and 95% confidence interval (Cl) for the MPO -463G/A polymorphism and CAD risk were calculated, and potential sources of heterogeneity and publication bias were explored. Statistical analysis was performed with the software program of Stata 9.0.

Results:,5 case-control studies were finally identified for analyses, involving 1938 cases with CAD and 1990 controls. We found that the MPO -463G/A polymorphism has no significant association with overall CAD risk (GIG vs A/A: OR = 0.595, 95%CI = 0.298-1.188, P = 0.141; GIG vs G/A + A/A: OR = 0.886, 95%CI = 0.779-1.008, P = 0.066; G/G + G/A vs A/A: OR = 0.611, 95%CI = 0.334-1.119, P = 0.111; OR = 0.886, 95%CI = 0.779-1.008, P = 0.066; G vs A: OR = 0.843, 95%CI = 0.675-1.053, P = 0.133). The heterogeneity test showed that there were significant differences between individual studies in additive, recessive and allelic genetic models (P = 0.008, P = 0.021, P = 0.019, respectively); further analyses revealed that age and sex possibly account for the heterogeneity.

Conclusions: Our meta-analysis demonstrated the evidence that there was no significant association between the MPO -463G/A polymorphism and the risk of CAD; larger and well-designed multicenter studies are needed to confirm our results. (C) 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

语种英语
WOS记录号WOS:000326362100005
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62405
专题北京大学第二临床医学院
作者单位1.CAPF, Sichuan Prov Hosp, Dept Cardiol, Leshan 614000, Peoples R China
2.Peking Univ, Peoples Hosp, Mol & Genet Unit, Dept Obstet & Gynecol, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Chang, Cuixian,Gao, Baorong,Liu, Zheng,et al. The myeloperoxidase-463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls[J]. CLINICAL BIOCHEMISTRY,2013,46(16-17):1644-1648.
APA Chang, Cuixian,Gao, Baorong,Liu, Zheng,Mao, Jianbin,&Jiang, Guoqiang.(2013).The myeloperoxidase-463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls.CLINICAL BIOCHEMISTRY,46(16-17),1644-1648.
MLA Chang, Cuixian,et al."The myeloperoxidase-463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls".CLINICAL BIOCHEMISTRY 46.16-17(2013):1644-1648.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chang, Cuixian]的文章
[Gao, Baorong]的文章
[Liu, Zheng]的文章
百度学术
百度学术中相似的文章
[Chang, Cuixian]的文章
[Gao, Baorong]的文章
[Liu, Zheng]的文章
必应学术
必应学术中相似的文章
[Chang, Cuixian]的文章
[Gao, Baorong]的文章
[Liu, Zheng]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。